Company: CMND
Filing Date: 2025-01-22
Form Type: 20-F
Source: 0001213900-25-005490
Chunk: 262

Company: Clearmind Medicine Inc.
Filing Date: 2025-01-22
Form: 20-F
Item: Item 19
Chunk 262
---
 Financing”) an...  

Pursuant
to the Cash Financing, the Company issued 1,325 720.00 698,897

In
connection with the Cash Financing, the Company incurred finder’s fees of $ 69,890

Pursuant
to the Share Exchange, the Company issued 883 455,487 372,745 82,742 1.43 1.5 107.46

In
connection with the Share Exchange, the Company incurred finder’s fees of $ 50,000

On
June 29, 2022, the Company signed an amendment to the Xylo Agreement (“ Xylo Amended Agreement”), pursuant to which, in the
event of an initial public offering, Xylo would receive, in respect of the Cash Financing, for no additional consideration, the number
of shares necessary to maintain an ownership percentage of the Company’s shares equal to the level of ownership it had at the time
of the Xylo Agreement.

As
of October 31, 2022, the Company recorded the fair value of this derivative financial liability in the amount of $ 290,569

F-27

CLEARMIND
MEDICINE INC.

Notes to
the Consolidated Financial Statements

(Expressed
in United States Dollars)

  Warrants  

The
following table summarizes the changes in the Company’s warrants:

                                                                                                     Historic                                
  Balance, October                                                                       19,763                                      576.66  
  Issuance                                                                                1,923                                      243.75  
  Issuance of April 2023                                                              4,505,718                                       5.124  
  Issuance of September                                                               7,500,000                                        9.00  
  Issuance                                                                                   75                                    1,297.67  
  Expiration of warrants                                                               ( 11,430                                      922.98  
  Exercise                                                                            ( 784,584                                       5.124  
  Balance, October 31, 2023                                                          11,231,465      $                                 7.90  
  Number                                                                                826,781                                              
  Balance, October 31, 2023                                                          11,231,465      $                                 7.90  
  Issuance of January                                                                 1,500,000                                        1.60  
  Exercise of warrants                                                              ( 8,293,585                                        2.62  
  Expiration                                                                            ( 8